Skip to content

Efficacy of nitric-zinc complex in the treatment of genital warts

Comparative efficacy study between "Nitrizinc complex®" and cryotherapy in the treatment of external genital warts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN36102369
Enrollment
120
Registered
2020-04-03
Start date
2017-12-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ano genital warts Infections and Infestations Venereal warts

Interventions

Patients are assigned to one of the two arms according to a specially prepared block randomization list of 4 patients. Only after the enrollment of each patient does the statistician communicate to th
Nitrogen is an inert, non-flammable gas which, in the liquid state found -196 ° C, is a suitable temperature for the induction of cytolysis of the pathological tissue. Liquid nitrogen can be applied t
the evaluation includes three options: 1. Com

Sponsors

Isdin (Spain)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. First episode never treated 2. Number of lesions: 3 to 10 3. Size of the single lesion: 1-5 mm 4. Location: penis/vulva/perianal region

Exclusion criteria

Exclusion criteria: 1. Previously treated patients 2. Circumcised patients 3. Immunosuppressed patients due to pathological and/or iatrogenic causes 4. Patients with diabetes mellitus 5. Pregnant women

Design outcomes

Primary

MeasureTime frame
At the end of the four sessions and again at three months, the experimenter will evaluate the response to the treatment; the evaluation includes three options: 1. Complete regression 2. Partial regression (reduction = or> 50% of the number of lesions) 3. No regression (<50% reduction in the number of lesions)

Secondary

MeasureTime frame
The tolerability of the two treatments will be assessed by both the investigator and the patient after every treatment session and at the end of the study and will be expressed as good, moderate, poor after evaluation, of 3 parameters: 1. Pain reported by the patient and defined as: mild 1 - moderate 2 - intense 3 2. Itching reported by the patient and defined as: mild 1 - moderate 2 - intense 3 3. Inflammation (observed by the doctor) and defined as: erythema: 1 - erosion: 2 - blisters: 3 - ulcer: 4

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026